The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 23 January 2004, www.theannals.com, DOI 10.1345/aph.1D312.
 The Annals of Pharmacotherapy: Vol. 38, No. 3, pp. 494-497. DOI 10.1345/aph.1D312
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow For Our Patients
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Looney, M.
Right arrow Articles by Smith, K. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Looney, M.
Right arrow Articles by Smith, K. M

DRUG INFORMATION ROUNDS

Isotretinoin in the Treatment of Granuloma Annulare

Melissa Looney, PharmD

at time of writing, Student, College of Pharmacy, University of Kentucky, Lexington, KY; now, Clinical Staff Pharmacist, St. Joseph's Hospital, Lexington

Kelly M Smith, PharmD

Associate Professor, Pharmacy Practice and Science, College of Pharmacy; Director, Drug Information Center, University of Kentucky Chandler Medical Center

Reprints: Kelly M Smith PharmD, University of Kentucky Drug Information Center, 800 Rose St., C113, Lexington, KY 40536-0293, fax 859/323-2049, ksmit1{at}email.uky.edu

OBJECTIVE: To assess the utility and safety of isotretinoin in the treatment of granuloma annulare (GA).

DATA SOURCES: Searches of MEDLINE (1966-January 2003), EMBASE (1989-January 2003), International Pharmaceutical Abstracts (1970-2002), and Allied and Complementary Medicine Database (1985-2002) were conducted. Key terms included granuloma annulare, isotretinoin, retinoids, and antioxidants.

DATA SYNTHESIS: Isotretinoin may have proliferative and inhibitory effects on collagen synthesis that improve GA symptoms. Cases reporting use of isotretinoin in the treatment of GA were reviewed. Several reports detail the successful use of isotretinoin 0.5-1 mg/kg/day, primarily in the disseminated form of the disease. However, some patients required dosage decreases in response to drug-related liver function test elevations, and 2 instances of drug failure were identified.

CONCLUSIONS: Isotretinoin should be reserved for patients with disseminated or refractory GA. Potential serious adverse effects associated with its use require careful monitoring.

Key Words: granuloma annulare, isotretinoin, retinoids

Published Online, January 23, 2004. www.theannals.com, DOI 10.1345/aph.1D312




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.